Monday, 25 October 2021

FSN E–Commerce Ventures Limited IPO (Nykaa) IPO

 







 FSN e-commerce Ventures Pvt. Ltd. is a digital consumer technology platform offering a wide range of lifestyle products. Founded in 2012, the company is an omnichannel retailer of beauty, personal care, wellness and fashion products. FSN e-commerce functions through 2 business verticals, namely Nykaa and Nykaa Fashion.

The company also deals with manufacturing its own products, which are sold under its owned brands such as Nykaa Naturals, Nykaa Cosmetics and Kay Beauty.  Ahead of its IPO, Nykaa has transformed itself into a public entity under the name of FSN e-commerce Ventures Private Limited.

FSN E–Commerce Ventures Limited IPO (Nykaa) IPO Objectives

  • To fund general corporate expenditures.
  • To meet the capital expenses.
  • For its operational expansion.

FSN E–Commerce Ventures Limited IPO  (Nykaa) IPO - Details

FSN e-commerce Ventures Private Limited has filed for its IPO with SEBI to raise
 Rs. 5,351.92 crores. The public offering would include a fresh issue of shares worth
 Rs. 630 crores along with an offer for sale of around 4.1 crore equity shares. 

  • Opening Date: Oct 28, 2021
  • Closing Date: Nov 1, 2021
  • Price Band: ₹1085 to ₹1125 per equity share
  • Market Lot: 12 Shares

FSN E–Commerce Ventures Limited IPO (Nykaa) IPO 

Important Dates

PO Open Date

Oct 28, 2021

IPO Close Date

Nov 1, 2021

Basis Of Allotment Date

Nov 8, 2021

Initiation Of Refunds

Nov 9, 2021

Credit Of Shares To
Demat ACcount

Nov 10, 2021

IPO Listing Date

Nov 11, 2021

Why Should You Invest in FSN E–Commerce Ventures Limited IPO (Nykaa) IPO?

FSN e-commerce Ventures Private Limited, previously known as Nykaa, is one of the largest lifestyle-oriented platforms. It is a leading retailer of luxury beauty and wellness brands catering to more than 5 million active users each month. The company has recently entered the unicorn club and comes with strong profitability and growth prospects. Moreover, it boasts of a robust financial performance in FY2020 and FY2021. With the increasing popularity of online platforms and the fast-expanding beauty industry in India, FSN e-commerce Ventures seem to be in a great spot.  Considering the current financial position of FSN e-commerce Ventures Private Limited, it is poised for impressive growth. Accordingly, investors should consider subscribing to the initial share sales of this company.

FSN E–Commerce Ventures Limited IPO (Nykaa) – Noteworthy Highlights

Here are some of the important highlights of FSN E–Commerce Ventures Limited IPO (Nykaa) that investors should be aware of:
- This Mumbai-based company has more than 75 offline stores across India.
- FSN e-commerce entered the unicorn club in 2020, raising about Rs. 166 crores in its Series 3 funding which was piloted by Steadview Capital.
- The company comes with over 75 offline stores throughout India, selling more than 35,000 products across 650+ brands.

 FSN E–Commerce Ventures Limited IPO (Nykaa) IPO - SWOT Analysis

  • Strengths
    • Updated product portfolio: Nykaa keeps updating its product range and offering, building a diversified portfolio. This has been instrumental in expanding its customer base. Moreover, by constantly updating the offerings, this company has put itself in a favourable position to tackle challenges posed by the dynamic business environment.
    • Impressive balance sheet: Nykaa’s strong balance sheet provides it with scope for expansion. It can utilise funds to finance new projects, which can diversify its revenue stream. This will have a positive impact on its key financial metrics, such as Return on Equity (ROE), Return on Sales (ROS), and more.
    • Efficient inventory management: This company works on an inventory model, which ensures that it has sufficient stock to meet the demand.
    • Strong social media presence: Nykaa runs social media marketing campaigns on a regular basis. This has played a vital role in boosting sales and acquiring customers.
  • Weaknesses

    • Implementation of technology: Nykaa has integrated technology in its backend processes. That said, it has not been able to make use of technological advantages in front end processes.
    • Low spending on research and development: Nykaa doesn’t spend a sufficient amount of funds on improving its research and development infrastructure. This can directly impact this company’s performance.
    • Handling customer grievances: Nykaa is still facing issues in addressing customers’ complaints efficiently. This can affect the company’s growth.
    • Delivery charges: Nykaa levies delivery charges if the order value is below a certain amount which eliminates potential buyers.
  • Opportunities

    • Growth prospect: With improvement in the standard of living, more individuals are making a shift towards e-commerce, which presents an excellent opportunity for Nykaa.
    • Improvements in AI: The company can take advantage of the developments in AI to estimate consumer demand and fulfil the requirements of niche segments.
    • E-commerce business model: Nykaa’s e-commerce business model can assist this company in collaborating with local suppliers logistic companies that belong to international markets. Besides this, the social media growth of the company can enable it to gain access to a large number of potential customers with a low marketing budget.
  • Threats

    • Change in domestic rules: As we advance, in case any changes take place regarding domestic laws and tax liability, it could affect Nykaa’s plans.
    • Growing competition: The number of competitors both online and offline is increasing. Accordingly, there’s always a possibility of losing customers.
    • Drop in expenditure: If consumers’ expenditure level drops, it can affect the profitability of this company.

 - FSN e-commerce Ventures Private Limited sells 25 products every 60 seconds.

- Before going for its public offer, FSN e-commerce Ventures Private Limited completed its acquisition of online jewellery brand Pipa Bella in April 2021.

If you’re a new investor open dmat account  for free with Angel One to begin your investment journey use link https://5minwebsite.angelbroking.com/Diykyc/SubbrokerLead?SbTag=U1RMSA==&BType=T0xE&a=0.

Recommendation: Subscribe for long term investment

 

Friday, 22 October 2021

HDFC NIFTY Next 50 Index Fund NFO

 


About NIFTY Next 50 Index

  • Represents 50 companies from NIFTY 100 after excluding the constituents of NIFTY 50. 
  •  Cumulative weight of index constituents that are not available for trading in F&O segment (Non F&O stocks) is capped at 15% on quarterly rebalance dates. 
  •  Weightages of non F&O stocks in the index are individually capped at 4.5% on quarterly rebalance dates. 
  •  Index Re-Balancing : Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year.

Investment Objective 

To generate returns that are commensurate (before fees and expenses) with the performance of the NIFTY Next 50 Index TRI (Underlying Index), subject to tracking error. There is no assurance that the investment objective of the Scheme will be realized

Reasons to invest in NIFTY Next 50 Index 

  • Offers Diversification Benefit at stocks and sector Level
  • Offers higher potential for growth with next league of probable Blue Chips
  • Provides Exposure to unique businesses
  • Could generate better Risk Adjusted Returns in Long Term
NIFTY Next 50 : Diversified with a different flavour

Top 3 sectors’ weight at 58% as compared to 67% for NIFTY 5



NIFTY Next 50 : Offers balanced allocation
NIFTY Next 50 Index median stock exposure is around 1.80% as compared to NIFTY 50 index median of 0.97%


Performance Journey : NIFTY 50 Vs NIFTY Next 50


Fund details
  • New Fund Offer Opens On:    October 22, 2021 
  • New Fund Offer Closes On:    October 29, 2021
  • Scheme Reopens on:                Within 5 Business Days of allotment of units under NFO

This product is suitable for investors who are seeking

  • Returns that are commensurate (before fees and expenses) with the performance of the NIFTY Next 50 Index (TRI) over long term, subject to tracking error.
  • Investment in equity securities covered by the NIFTY Next 50 Index


LICMF Balanced Advantage Fund NFO

 



NFO Details:
  • New Fund Offer Opens on: 20/10/2021 
  • New Fund Offer Closes on: 03/11/2021 
  • Scheme Reopens on: 15/11/2021
About LICMF Balanced Advantage Fund (LICMF BAF)
  • A  type of Hybrid Fund 
  • Adopts asset allocation strategy 
  • Using FDMM (Fundamental Driven Mathematical Model) 
  • Equity allocation may increase or decrease depending on the model output. 
  • Our Model considers current economic outlook & fundamentals of corporate world. 
Investment Objective
The investment objective of the scheme is to provide capital appreciation/ income to the investors from a dynamic mix of equity, debt and money market instruments. The Scheme seeks to reduce the volatility by diversifying the assets across equity, debt and money market instruments. However, there is no assurance or guarantee that the investment objective of the Scheme will be realized.

How LIC MF BAF is different from existing schemes of LICMF? 
LIC MF BAF is an open ended hybrid fund that dynamically manages portfolio of equity and equity related instruments (including derivative/ arbitrage exposure), debt and money market instruments. The fund endeavours to reduce the volatility, minimizes the downside during falling market and participate in upside during the rising market.  

LICMF BAF Portfolio Construct
  • Equity 
    • Stock Selection
    • Capital Appreciation
  • Arbitrage
    • Provide Hedge
    • Endeavour Equity Tax Benefit 
  • Debt 
    • Stability
    • Liquidity  
Features
  • Dynamic Asset allocation using Fundamental Parameters 
  • Net Equity allocation can range from 0% to 100% 
  • Rebalancing of portfolio happens on dynamic basis 
  • 1% exit load for redemption before 1 year to be charged only above 12% of units allotted 
This product is suitable for investors who are seeking*

  • Capital appreciation over a long period of time.
  • Investments in a dynamically managed portfolio of equity and equity related instruments, debt and money market instruments.
  • Risk – Very High 



Wednesday, 20 October 2021

Aditya Birla Sun Life NASDAQ 100 FOF NFO

 

 


What it is?
An open-ended fund of fund investing in units of overseas ETFs and/or Index fund based on the NASDAQ-100 Index

Investment objective
To provide long-term capital appreciation by investing in units of overseas ETFs and/or Index Fund based on NASDAQ-100 Index

The NASDAQ-100 Index® enlists 100 of the top non-financial companies of the world including category defining companies that are leaders in tech-led innovation and disruption. Represents ‘new economy’ fast growing sectors and themes, with tech leading the way.

NFO Details

NEW FUND OFFER OPENS ON:          Friday, October 15, 2021 

NEW FUND OFFER CLOSES ON:        Friday, October 29, 2021 

SCHEME RE-OPENS ON:                     Within 5 business days from date of allotment

Why should you invest in Aditya Birla Sun Life NASDAQ 100 FOF?

  • Portfolio exposure to global innovators and disruptors Invest in innovation and growth through global value creators of the NASDAQ-100 Index®
  • Diversification across sectors and themes  Access to ‘new economy’ fast growing sectors and innovative, path breaking themes
  • Low correlation to Indian equity market Has investing scale and themes largely unrepresented in Indian market
  • Long term capital growth potential Innovation to drive growth over the long term for your portfolio.
  • Currency depreciation Global investing to multiply value owing to currency depreciation.

This product is suitable for investors who are seeking:

  • Long term capital appreciation
  • Return that corresponds generally to the performance of the NASDAQ-100 Index, subject to tracking error

 


ICICI Prudential Smallcap Index Fund NFO





An open-ended mutual fund 

ICICI Pru Small cap Index Fund invests in small cap companies that are part of NIFTY Small Cap 250 Index. Small cap index has beaten all indices and provided superior returns in the medium to long term.

What is Nifty Small cap 250 Index?

  • Nifty Small cap 250 index consists of 250 companies that are ranked from 251-500 from NIFTY 500.
Small cap Universe: Full of Potential 
  • GROWTH PROSPECTS
    • Small Cap companies tend to have higher growth prospects owing to their smaller size
  • DIVERSIFICATION
    • Higher weightage to sectors under-represented in Large & Mid Cap segments
  • ACCESS TO NEW IPOS
    • Index could endeavor to capture newly listed companies ; can be a gateway to access IPOs
  • POTENTIAL LEADERS 
    • Many specialized businesses, expected to be the leaders of their sector, are part of the index 
  • INNOVATIVE
    • Start-ups and Unicorns could get included in this space with their listing 
  • CONTENDERS FOR MIDCAP
    • Many small cap companies grow to be midcaps in the future, delivering impressive growth in the process  

NFO Issue Details

Scheme Opens

12-Oct-21

Scheme Closes

26-Oct-21

NAV of the fund

Rs 10 during NFO period

Benchmark

Nifty Small cap 250 TRI

Minimum Amount for Application in the NFO

Rs. 100/- plus in multiple of Re.1

Asset Allocation 

Type of instruments

Min %

Max %

Risk Profile

Equity and Equity related securities of companies constituting the underlying index (NIFTY Small cap 250 Index)

95%

100%

Medium to High

Money Market instruments including TREPs and Units of debt schemes

0%

5%

Low to Medium

Units of Debt ETFs

0%

5%

Low to Medium


Where will the Scheme invest?
  • Equity and equity related securities forming part of underlying index, including warrants carrying the right to obtain equity shares. 
  • Derivative instruments like Stock / Index Futures, Stock / Index Options and such other derivative instruments permitted by SEBI. 
  • Units of debt schemes/ ETFs, subject to applicable regulations. 
  • Money market instruments including TREPs Or similar instruments as may be permitted by SEBI/RBI from time to time.
Why Invest in the ICICI Prudential Small cap Index Fund?
  • TRUE REPRESENTATION
    • The Nifty Smallcap 250 index captures all the 250 stocks in the smallcap space
  • GROWTH POTENTIAL
    • Smallcap companies tend to have higher growth rates, which might come at the cost of higher volatility
  • NON-DEMAT INVESTORS
    • An Index fund facilitates passive investing for investors without a demat account 
  • LOW CAPITAL REQUIREMENT
    • For a minimum investment amount of INR 100, get exposure to all 250 Smallcap stocks 
  • SIP
    • Index fund offers the benefits of systematic investment with various frequencies 
  • LOW COST
    • Index funds by virtue of replicating the underlying index, tends to have costs lower than comparable actively managed funds  


Performance of Small cap 250 Index

  • 1 Year Returns – 88%
  • 5-year annualized returns – 15%
  • Annualized returns since inception – 16%


ITI PHARMA AND HEALTHCARE FUND NFO




  (An open ended equity scheme investing in Pharma and Healthcare)

What is ITI Pharma and Healthcare Fund?
  • ITI Pharma and Healthcare Fund is a fund which will invest in equity and equity related securities of companies engaged in Pharma and Healthcare.

Why invest in Pharma Fund?
  • Benefit from increased importance of Healthcare in the post Covid-19 Era
  • Flexibility to invest across market caps and investing styles to optimize risk return payoffs
  • Diversification benefits with Healthcare sub-sectors
  • Potentially lower volatility as historically seen in this sector as it is a defensive play
  • Capitalize on changing trends that are reshaping the global Pharma and Healthcare industry

Product features
  • Exposure to one of the most rapidly growing & evolving businesses in India
  • Market Cap Agnostic approach to Portfolio Construction
  • Allocations across healthcare ecosystem like Domestic Pharma, Global Pharma, Diagnostics, Hospitals, Wellness and medical devices
  • The fund can be suitable for long-term equity investors who have an investment horizon of 4-5 years at least.
  • Bottom up valuation based approach to analyze business and market cycles
NFO Details

New Fund Offer Opens on

October 18, 2021

New Fund Offer Closes on

November 01, 2021

Scheme reopens for continuous sale and repurchase on or before

November 17, 2021    


Name of the Scheme

ITI Pharma and Healthcare Fund

Type of Scheme

An open ended equity scheme investing in Pharma and Healthcare

Investment objective

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Minimum application amount

Rs. 5,000/- and in multiples of Rs. 1/- thereafter


ASSET ALLOCATION

Instruments

Indicative Allocation (% of net assets)

Risk Profile

Maximum

Minimum

Low / Medium / High

Equity & Equity related instruments of companies engaged in Pharma and Healthcare

100%

80%

High

Equity and Equity related securities of other Companies

20%

0%

High

Listed Preference Shares

10%

0%

Medium to High

Debt and Money Market Instruments

20%

0%

Low to Medium

Units issued by REITs and InvITs

10%

0%

Medium to High


KEY FEATURES

  • Exposure
    • Exposure to one of the most rapidly growing and evolving businesses in India
  • Suitability
    • The fund can be suitable for long-term equity investors who have an investment horizon of 4-5 years atleast
  • Allocation
    • Allocations across healthcare ecosystem like Domestic Pharma, Global Pharma, Diagnostic, Hospitals, wellness and medical devices
  • Valuation Approach
    • Bottom up valuation based approach to analyse business and market cycle


Pentagon Rubber Ltd SME

About    Pentagon Rubber Ltd SME Pentagon Rubber Limited is a manufacturer of Rubber Conveyor Belt in India. The company is manufacturing Ru...